Positron emission tomography imaging using radiolabeled inorganic nanomaterials.
暂无分享,去创建一个
[1] S. Gambhir. Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.
[2] Jesse V Jokerst,et al. Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.
[3] Stephen J Archibald,et al. Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals. , 2014, Journal of labelled compounds & radiopharmaceuticals.
[4] D. Goldenberg. Targeted therapy of cancer with radiolabeled antibodies. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Younan Xia,et al. Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. , 2013, Nano letters.
[6] Jan Grimm,et al. Cerenkov Luminescence Imaging of Medical Isotopes , 2010, Journal of Nuclear Medicine.
[7] C. Anderson,et al. Molecular Imaging of Cancer with Copper‐64 Radiopharmaceuticals and Positron Emission Tomography (PET) , 2009 .
[8] Dingbin Liu,et al. Chelator-Free 64Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy , 2014, ACS nano.
[9] Hua Ai,et al. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. , 2011, Accounts of chemical research.
[10] C. Anderson,et al. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. , 2010, Chemical reviews.
[11] Hao Hong,et al. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.
[12] Dean Ho,et al. Cancer Nanomedicine: From Drug Delivery to Imaging , 2013, Science Translational Medicine.
[13] J. Engle,et al. 89Zr radiochemistry for positron emission tomography. , 2011, Medicinal chemistry (Shariqah (United Arab Emirates)).
[14] M. Welch,et al. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. , 2000, Bioconjugate chemistry.
[15] Sanjiv S. Gambhir,et al. Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature , 2007, Journal of Nuclear Medicine.
[16] P. Choyke. Nanoparticles: Take Only Pictures, Leave Only Footprints , 2014, Science Translational Medicine.
[17] Chris Orvig,et al. Matching chelators to radiometals for radiopharmaceuticals. , 2014, Chemical Society reviews.
[18] Yan Xing,et al. Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.
[19] Fan Zhang,et al. The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development. , 2014, Biomaterials.
[20] Kai Liu,et al. Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. , 2012, ACS nano.
[21] Yong Ding,et al. Self-Illuminating 64Cu-Doped CdSe/ZnS Nanocrystals for in Vivo Tumor Imaging , 2014, Journal of the American Chemical Society.
[22] Kai Chen,et al. Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[23] W. Kreyling,et al. Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators , 2011, Archives of Toxicology.
[24] Dong Liang,et al. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. , 2010, Journal of the American Chemical Society.
[25] M. Meyerand,et al. Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging , 2014, Advanced materials.
[26] Simon M. Ametamey,et al. Molecular Imaging with PET , 2008 .
[27] Peng Huang,et al. PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters. , 2014, Biomaterials.
[28] H. Choi,et al. Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. , 2013, Biomaterials.
[29] Xing-Jie Liang,et al. Theranostic nanoparticles engineered for clinic and pharmaceutics. , 2011, Accounts of chemical research.
[30] Kai Chen,et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.
[31] Zhen Cheng,et al. Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. , 2010, Small.
[32] Jinwoo Cheon,et al. Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology , 2009 .
[33] Fan Zhang,et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. , 2011, Nano letters.
[34] Mingyuan Gao,et al. In situ 111In-doping for achieving biocompatible and non-leachable 111In-labeled Fe3O4 nanoparticles. , 2014, Chemical communications.
[35] K. Prasad,et al. Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage. , 2004, The British journal of radiology.
[36] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[37] Heather M. Hennkens,et al. Radiometals for combined imaging and therapy. , 2013, Chemical reviews.
[38] Teófilo Rojo,et al. The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity. , 2013, Accounts of chemical research.
[39] Karen L Wooley,et al. Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. , 2014, Angewandte Chemie.
[40] Jordi Llop,et al. Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles. , 2013, ACS nano.
[41] J. Bading,et al. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] O. Muzik,et al. PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] Mithat Gönen,et al. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe , 2014, Science Translational Medicine.
[44] Bing Wang,et al. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. , 2013, Accounts of chemical research.
[45] Hak Soo Choi,et al. Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.
[46] Xin Cai,et al. Radioactive 198Au-Doped Nanostructures with Different Shapes for In Vivo Analyses of Their Biodistribution, Tumor Uptake, and Intratumoral Distribution , 2014, ACS nano.
[47] H. Dai,et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.
[48] Jordi Llop,et al. Tracing nanoparticles in vivo: a new general synthesis of positron emitting metal oxide nanoparticles by proton beam activation. , 2012, The Analyst.
[49] Erin Lavik,et al. The role of nanomaterials in translational medicine. , 2011, ACS nano.
[50] Qian Liu,et al. 18F-Labeled magnetic-upconversion nanophosphors via rare-Earth cation-assisted ligand assembly. , 2011, ACS nano.
[51] H. Hong,et al. In a "nutshell": intrinsically radio-labeled quantum dots. , 2012, American journal of nuclear medicine and molecular imaging.
[52] Luis M. De Leon-Rodriguez,et al. The synthesis and chelation chemistry of DOTA-peptide conjugates. , 2008, Bioconjugate chemistry.
[53] Yadong Yin,et al. Cation Exchange Reactions in Ionic Nanocrystals , 2004, Science.
[54] Yin Zhang,et al. PET tracers based on Zirconium-89. , 2011, Current radiopharmaceuticals.
[55] David A Mankoff,et al. A definition of molecular imaging. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] Hao Hong,et al. Chelator-free synthesis of a dual-modality PET/MRI agent. , 2013, Angewandte Chemie.